Protagenic Therapeutics’s (MBP0) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Protagenic Therapeutics is a Sell.
Protagenic Therapeutics’s (MBP0) 20-Day exponential moving average is EUR 1.59, while Protagenic Therapeutics’s (MBP0) share price is EUR 1.59, making it a Sell.
Protagenic Therapeutics’s (MBP0) 50-Day exponential moving average is EUR 1.59, while Protagenic Therapeutics’s (MBP0) share price is EUR 1.59, making it a Sell.
Protagenic Therapeutics’s (MBP0) 10-Day exponential moving average is EUR 1.59, while Protagenic Therapeutics’s (MBP0) share price is EUR 1.59, making it a Sell.
Protagenic Therapeutics’s (MBP0) 100-Day exponential moving average is EUR 1.59, while Protagenic Therapeutics’s (MBP0) share price is EUR 1.59, making it a Sell.
Protagenic Therapeutics’s (MBP0) stock price is EUR 1.59 and Protagenic Therapeutics’s (MBP0) 50-day simple moving average is EUR 1.59, creating a Buy signal.
Protagenic Therapeutics’s (MBP0) stock price is EUR 1.59 and Protagenic Therapeutics’s (MBP0) 100-day simple moving average is EUR 1.59, creating a Buy signal.
Protagenic Therapeutics’s (MBP0) stock price is EUR 1.59 and Protagenic Therapeutics’s (MBP0) 200-day simple moving average is EUR 1.59, creating a Sell signal.